Key result
African Americans show ~45% greater sensitivity to alpha-1-adrenoceptor-mediated venoconstriction versus Caucasians.
Why the study?
Does African American ethnicity alter venous sensitivity to alpha-1-adrenoceptor stimulation compared to Caucasian ethnicity?
Observational (n=106)
Single-blind (analyst unaware of ethnicity)
No
Does African American ethnicity alter venous sensitivity to alpha-1-adrenoceptor stimulation compared to Caucasian ethnicity?
These findings suggest a generalized increased sensitivity to alpha-1-adrenoceptor-mediated vasoconstriction in African Americans, which may predispose to the higher prevalence of hypertension in this population.
Answers are grounded in this paper and cite their sources.
Greater alpha-1 venoconstriction sensitivity in African Americans may contribute to hypertension disparities; hypothesis-generating and requires prospective confirmation before clinical consideration.
Blacks have increased hemodynamic responses to both physiological and pharmacological adrenergic stimulation compared with whites, and this may contribute to the greater prevalence of hypertension in this ethnic group. A small study suggested enhanced α1-adrenoreceptor-mediated arterial vasoconstriction in the forearm vasculature of blacks compared with whites, but it is unknown whether this reflects a generalized vascular phenomenon. The objective of this study was to examine the hypothesis that there are ethnic differences in venous α1-adrenoreceptor responsiveness. Using a linear variable differential transformer, we measured local dorsal hand vein responses to increasing doses of the selective α1-adrenoreceptor agonist, phenylephrine, in 106 subjects (64 whites and 42 blacks). There was wide interindividual variability in responses to phenylephrine. The dose that produced 50% of maximal constriction (ED50) ranged from 11 to 5442 ng/min, and maximal venoconstriction (Emax) ranged from 13.5% to 100%. Blacks (geometric mean ED50 =172 ng/min; 95% confidence interval, 115-256 ng/min) were more sensitive to phenylephrine than whites (310 ng/min; 95% confidence interval, 222-434 ng/min; unadjusted P=0.026; adjusted P=0.003). Median Emax was slightly higher in blacks (89%; interquartile range, 82% to 98%) compared with whites (85%; interquartile range, 75% to 95%; P=0.07). Taken together with previous findings in arterial vessels, our results suggest a generalized increased sensitivity to α1-adrenoreceptor-mediated vasoconstriction in blacks. Increased vascular α-adrenoreceptor sensitivity could predispose to hypertension, and future studies addressing the contribution of this mechanism to ethnic differences in the prevalence of hypertension will be of interest.
No takes yet. Share an insight, caveat, or question.
Adefurin et al. (2013) conducted an observational in Healthy volunteers (n=106). African American ethnicity vs. Caucasian ethnicity was evaluated on Dose of phenylephrine producing 50% of maximal venoconstriction (ED50) (geometric mean ED50 172 ng/min vs 310 ng/min (45% lower), p=0.003). African Americans had greater sensitivity to alpha-1-adrenoceptor-mediated venoconstriction compared to Caucasians, with a 45% lower geometric mean ED50 for phenylephrine.
Synapse has enriched 10 related papers. Consider them for comparative context: